Drug · DIN 02412691
ACT DUTASTERIDE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 18, 2019; first marketed September 5, 2014.
- Drug Identification Number (DIN)
- 02412691
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Dutasteride G04CB02
- Class
- Human
- Record last updated
- July 31, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DUTASTERIDE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 3, 2018: NOC 20237Abbreviated New Drug Submission (ANDS) · Merger - buyout
- October 3, 2014: NOC 16160Supplement to an Abbreviated New Drug Submission (SANDS) · New presentation
- July 18, 2014: NOC 15841Abbreviated New Drug Submission (ANDS)